Skip to main content
. 2018 Jun 2;155:229–243. doi: 10.1016/j.ejmech.2018.05.059

Fig. 1.

Fig. 1

First series of cycloguanil-based dihydrotriazines, previously identified as dual inhibitors of influenza virus and RSV, and the novel series of azaspiro dihydrotriazines 123.